SNTI Senti Biosciences Inc.

Price (delayed)

$2.355

Market cap

$10.78M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$14.4

Enterprise value

$19.75M

Highlights
SNTI's EPS is up by 24% year-on-year and by 10% since the previous quarter
SNTI's net income is up by 9% from the previous quarter
SNTI's gross profit has dropped by 71% year-on-year and by 50% since the previous quarter
The revenue has plunged by 71% YoY and by 50% from the previous quarter

Key stats

What are the main financial stats of SNTI
Market
Shares outstanding
4.58M
Market cap
$10.78M
Enterprise value
$19.75M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.19
Price to sales (P/S)
8.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.49
Earnings
Revenue
$1.28M
EBIT
-$64.45M
EBITDA
-$58.49M
Free cash flow
-$53.21M
Per share
EPS
-$14.4
Free cash flow per share
-$11.64
Book value per share
$12.26
Revenue per share
$0.28
TBVPS
$22.36
Balance sheet
Total assets
$102.19M
Total liabilities
$46.09M
Debt
$36.72M
Equity
$56.09M
Working capital
$46.06M
Liquidity
Debt to equity
0.65
Current ratio
5.79
Quick ratio
2.9
Net debt/EBITDA
-0.15
Margins
EBITDA margin
-4,587.1%
Gross margin
100%
Net margin
-5,054.7%
Operating margin
-7,726.3%
Efficiency
Return on assets
-51.9%
Return on equity
-85%
Return on invested capital
-57.2%
Return on capital employed
-69.6%
Return on sales
-5,054.7%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

SNTI stock price

How has the Senti Biosciences stock price performed over time
Intraday
-2.28%
1 week
659.68%
1 month
805.77%
1 year
164.31%
YTD
256.82%
QTD
741.07%

Financial performance

How have Senti Biosciences's revenue and profit performed over time
Revenue
$1.28M
Gross profit
$1.28M
Operating income
-$98.51M
Net income
-$64.45M
Gross margin
100%
Net margin
-5,054.7%
Senti Biosciences's operating margin has shrunk by 113% QoQ
The net margin has plunged by 82% from the previous quarter
SNTI's gross profit has dropped by 71% year-on-year and by 50% since the previous quarter
The revenue has plunged by 71% YoY and by 50% from the previous quarter

Growth

What is Senti Biosciences's growth rate over time

Valuation

What is Senti Biosciences stock price valuation
P/E
N/A
P/B
0.19
P/S
8.44
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
15.49
SNTI's EPS is up by 24% year-on-year and by 10% since the previous quarter
Senti Biosciences's equity has shrunk by 50% YoY and by 16% QoQ
SNTI's P/B is 33% below its last 4 quarters average of 0.3
The revenue has plunged by 71% YoY and by 50% from the previous quarter
The P/S is 11% less than the last 4 quarters average of 9.7

Efficiency

How efficient is Senti Biosciences business performance
SNTI's return on sales has dropped by 82% since the previous quarter
The ROE has plunged by 74% YoY and by 8% from the previous quarter
The ROA has contracted by 46% YoY

Dividends

What is SNTI's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for SNTI.

Financial health

How did Senti Biosciences financials performed over time
The company's total assets is 122% higher than its total liabilities
The quick ratio has dropped by 54% year-on-year and by 7% since the previous quarter
The company's total assets fell by 37% YoY and by 14% QoQ
The debt is 35% less than the equity
SNTI's debt to equity has surged by 91% year-on-year and by 16% since the previous quarter
Senti Biosciences's equity has shrunk by 50% YoY and by 16% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.